Arlington Partners’s CME Group CME Stock Holding History

Arlington Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$186K	Buy	843 +49	+6%	+$13.6K	0.34%	58
2026 Q1	$235K	Buy	+794	New	+$236K	0.47%	54
2025 Q4	–	Sell	-18,787	Closed	-$5.08M	–	16
2025 Q3	$5.08M	Buy	18,787 +10,894	+138%	+$2.96M	1.75%	20
2025 Q2	$2.18M	Buy	+7,893	New	+$2.15M	0.8%	60
2023 Q3	–	Sell	-667	Closed	-$124K	–	415
2023 Q2	$124K	Sell	667 -208	-24%	-$38.4K	0.02%	214
2023 Q1	$168K	Buy	875 +713	+440%	+$129K	0.02%	142
2022 Q4	$27.2K	Buy	+162	New	+$28.2K	﹤0.01%	277
2020 Q3	–	Sell	-13	Closed	-$2K	–	144
2020 Q2	$2K	Hold	13	–	–	﹤0.01%	159
2020 Q1	$2K	Buy	+13	New	+$2.59K	﹤0.01%	244

Other funds holding CME

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Arlington Partners's CME Position: Q2 2026 in Review

Arlington Partners increased its CME Group (CME) stake by 6.2% in Q2 2026, buying an estimated $13.6K and bringing the position to 843 shares worth $186K. The position accounts for 0.34% of the portfolio, ranked #58.

Arlington Partners first reported a position in CME in Q1 2020 and has held it in 9 quarters since. The position peaked at $5.08M in Q3 2025. 239 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Arlington Partners held 843 shares of CME Group worth $186K as of Q2 2026.
Arlington Partners bought 49 CME Group shares in Q2 2026, an estimated $13.6K.
CME Group made up 0.34% of Arlington Partners's portfolio in Q2 2026, its #58 holding.
Arlington Partners first reported a position in CME Group in Q1 2020 and has held it in 9 quarters since.
Arlington Partners's CME Group position peaked at $5.08M in Q3 2025.
239 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Arlington Partners's 13F filing for Q2 2026, filed 7 Jul 2026.